Antimycin A as a mitochondrial electron transport inhibitor prevents the growth of human lung cancer A549 cells

63Citations
Citations of this article
74Readers
Mendeley users who have this article in their library.

Abstract

Antimycin A (AMA) inhibits mitochondrial electron transport between cytochromes b and c. We evaluated the effects of AMA on the growth of human pulmonary adenocarcinoma A549 cells in relation to cell cycle and apoptosis. Treatment with 2-100 μM AMA significantly inhibited the cell growth of A549 for 72 h. DNA flow cytometry indicated that AMA slightly induced a G1 phase arrest of the cell cycle for 72 h. Treatment with 50 μM AMA induced apoptosis of ∼17% in view of annexin V-staining cells. The dose of 50 μM AMA also induced loss of the mitochondrial membrane potential (Δψm) of ∼38%. The intracellular reactive oxygen species (ROS) levels including O2•- were significantly increased in AMA-treated A549 cells. In conclusion, AMA inhibited the growth of A549 cells via inducing cell cycle arrest as well as triggering apoptosis. Growth inhibition in AMA-treated A549 cells was accompanied by an increase in ROS levels.

Cite

CITATION STYLE

APA

Han, Y. H., Kim, S. H., Kim, S. Z., & Park, W. H. (2008). Antimycin A as a mitochondrial electron transport inhibitor prevents the growth of human lung cancer A549 cells. Oncology Reports, 20(3), 689–693. https://doi.org/10.3892/or_00000061

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free